Last reviewed: June 20, 2026
Last updated: June 20, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide triggers changes in your gut and brain signaling within days of your first injection, which is why many patients notice gastrointestinal symptoms before other effects appear. Clinical trials show that roughly 25% of people experience nausea in the first week, though intensity varies widely based on individual metabolism and starting dose. Knowing what to expect helps you distinguish normal adjustment from concerning reactions.
Semaglutide Side Effects During Your First Week
Nausea ranks as the earliest and most common side effect, often beginning within 24 to 72 hours of your first injection. This happens because semaglutide activates GLP-1 receptors in your stomach and brain simultaneously, slowing digestion and signaling fullness. Most people report mild to moderate nausea that peaks around day three or four, then gradually improves as your body adapts.
Other first-week symptoms may include mild fatigue, loss of appetite, or a subtle change in how food tastes. Some patients describe food aversions during this initial phase—certain flavors or textures may suddenly feel unappealing. These early reactions typically subside within 5 to 7 days as your system acclimates to the medication's presence.
Second and Third Week Response: When Most Adjustment Occurs
By week two, many patients experience a shift from nausea toward digestive changes like constipation, loose stools, or mild bloating. This transition reflects your gut adapting to slower movement and altered signaling from the GLP-1 pathways. Most people find these digestive symptoms less bothersome than initial nausea because they can often manage them with hydration and dietary adjustments.
Week three typically brings a stabilization phase where side effect intensity plateaus or begins to decline. Your body's sensitivity to semaglutide normalizes, and the medication's appetite-suppressing effect becomes the dominant experience rather than physical discomfort. Clinical data suggests that by day 21, roughly 60% of patients report their symptoms as mild or nearly resolved.
The Four-Week Mark: When Most Patients Feel Better
By the end of four weeks, the majority of semaglutide users experience a significant reduction in side effects while retaining the therapeutic benefits of appetite suppression and blood sugar control. Residual symptoms tend to be manageable—occasional mild nausea, predictable digestion patterns, or subtle energy shifts that don't interfere with daily life. This timeline aligns with clinical trial data showing symptom burden declining sharply after week three.
However, the four-week mark is also when some patients begin their next injection cycle or dose escalation (if prescribed), which can temporarily reintroduce mild symptoms. This is expected and normal; tolerance often builds more quickly the second time. PlexusDx providers monitor this progression and can adjust timing or dosing strategy based on your individual response.
Why Side Effect Timing Varies From Person to Person
Your genetic makeup, starting metabolic rate, and baseline digestive sensitivity all influence when and how intensely semaglutide side effects appear. Someone with fast gastric emptying may experience nausea later than someone with slower baseline digestion. Additionally, patients taking semaglutide alongside other medications or managing pre-existing conditions may have a different symptom timeline than those starting fresh.
PlexusDx Precision Peptide Genetic Test reveals how variants in your GLP1R gene (rs6923761) and other peptide-pathway genes affect your response to semaglutide. Understanding your genetic predisposition helps your provider anticipate whether you'll fall into the fast-responder, slow-responder, or moderate-responder category, allowing for personalized timing and dose adjustments. This $99 add-on test maps 14 pathways and 49 peptides to optimize your treatment plan from the start.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
When will I feel nausea if I'm taking semaglutide?
Nausea typically begins within 24 to 72 hours of your first injection and peaks around day three or four. Most patients experience mild to moderate nausea that resolves within 5 to 7 days as their body adapts. If nausea persists beyond two weeks or becomes severe, contact your PlexusDx provider for guidance on timing or dosing adjustments.
How long do semaglutide side effects last in clinical trials?
Clinical trial data shows that roughly 60% of patients report substantially improved or resolved side effects by week four of treatment. Most common side effects—nausea, fatigue, and appetite loss—follow a predictable pattern of peak intensity in days 3–5, then gradual decline through week three. Longer-term side effects like constipation may persist intermittently but typically become manageable with hydration and dietary strategies.
What is PlexusDx Semaglutide Injection pricing, and how does it work?
PlexusDx Compounded Semaglutide Injection starts at $149 per month flat, with no per-dose your dose may need to go up - your price won't adjusts. All medications come from licensed 503A compounding pharmacies, no insurance is required, and HSA/FSA accounts are eligible. Your dose may need to go up. Your price won't.
Are constipation and diarrhea normal semaglutide side effects?
Yes, both constipation and loose stools are common as semaglutide slows your digestion. Most patients experience constipation in weeks two to three, while others have variable stools. These symptoms typically improve with increased water intake, fiber from whole foods, and gentle movement. Persistent severe constipation should be reported to your provider.
Can genetic testing predict how I'll respond to semaglutide?
PlexusDx Precision Peptide Genetic Test identifies variants in your GLP1R gene and 13 other peptide-pathway genes that influence semaglutide sensitivity and side effect onset. This $99 add-on test after your first month maps how your genetics align with 150+ clinical insights, helping your provider anticipate your response timeline and personalize your treatment plan for fewer surprises.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
When Do You Start Seeing Weight Loss with Ozempic?
How Soon Does Ozempic Take Effect: Understanding Your Weight Loss Journey